DEXCOM INC (DXCM) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from DEXCOM INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

• FY 2025 MD&A filed 2026-02-12 · accession 0001093557-26-000027 · latest 10-K
• FY 2024 MD&A filed 2025-02-18 · accession 0001093557-25-000036
• FY 2023 MD&A filed 2024-02-08 · accession 0001093557-24-000021
• FY 2022 filed 2023-02-09 · accession 0001093557-23-000024 · MD&A text quarantined because Item 7 boundaries were low-confidence; no filing narrative is published for this year.
• FY 2021 filed 2022-02-14 · accession 0001093557-22-000014 · MD&A text quarantined because Item 7 boundaries were low-confidence; no filing narrative is published for this year.

Back to the DXCM company profile.